Incubation Center for Advanced Medical Science, Kyushu University, Fukuoka, Japan.
Incubation Center for Advanced Medical Science, Kyushu University, Fukuoka, Japan; Center for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan.
Clin Ther. 2018 Nov;40(11):1823-1827. doi: 10.1016/j.clinthera.2018.09.005. Epub 2018 Oct 24.
Although most pharmaceutical companies and bio-ventures have not yet created a practical business model or a credible exit thus far, most are expecting potential new business to be derived from regenerative medicine. This article discusses and proposes some ideas regarding a patent strategy for regenerative medicine.
PubMed literature searches were conducted to identify recent reports relevant to regenerative medicine. Information regarding patents and patent applications were obtained from the database service of the Japan Platform for Patent Information on the website of the National Center for Industrial Property Information and Training at https://www.j-platpat.inpit.go.jp/web/all/top/BTmTopEnglishPage and the Japan Patent Office at https://www.jpo.go.jp/index.htm.
The infrastructure of regenerative medicine in Japan is still maturing. Patent protection is important in regenerative medicine considering its special characteristics.
Based on the understanding of the special characteristics of regenerative medicine, this article discusses and proposes some ideas regarding a patent strategy for the field, which is different from that of a typical patent strategy as in the case of a small-molecule drug.
虽然大多数制药公司和生物风险企业迄今尚未建立切实可行的商业模式或可信的退出机制，但大多数企业都期望从再生医学中获得新的潜在业务。本文讨论并提出了一些关于再生医学专利策略的想法。
通过 PubMed 文献检索，确定了与再生医学相关的最新报告。专利和专利申请的信息是从日本工业产权信息和培训中心网站上的日本专利信息平台数据库服务（https://www.j-platpat.inpit.go.jp/web/all/top/BTmTopEnglishPage）和日本专利局（https://www.jpo.go.jp/index.htm）获得的。
日本再生医学的基础设施仍在成熟中。考虑到再生医学的特殊特征，专利保护在再生医学中非常重要。
基于对再生医学特殊特征的理解，本文讨论并提出了一些关于该领域专利策略的想法，这与小分子药物的典型专利策略有所不同。
